ILDSTAD SUZANNE (Chief Scientific Officer) sold 1.2% of their position (44.02K shares) of TOURMALINE BIO, INC. on the open market
Open‑market sale worth $112.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/14/2023ACC: 0001209191-23-037183
DirectorOfficer10% Owner· Chief Scientific Officer
Since May 2021
-23.52K
Net shares
Net seller
$112.3K
Total sold
3
Open market trades
0B · 3S
4
Total transactions
20.50K acquired · 44.02K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−16.87K
Price / share
$2.59
Trade value
$43.73K
% of position
0.4%
6/12/2023
3.82M→3.80M
Common Stock
Direct
Shares
−14.21K
Price / share
$2.56
Trade value
$36.34K
% of position
0.4%
6/13/2023
3.80M→3.78M
Common Stock
Direct
Shares
−12.94K
Price / share
$2.49
Trade value
$32.24K
% of position
0.3%
6/14/2023
3.78M→3.77M
Total
Net shares
−44.02K
Net value
-$112.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2023 | S · Sale | −16.87K | $2.59 | $43.73K | 0.4% | 3.82M | 3.80M |
| Common Stock Direct | 6/13/2023 | S · Sale | −14.21K | $2.56 | $36.34K | 0.4% | 3.80M | 3.78M |
| Common Stock Direct | 6/14/2023 | S · Sale | −12.94K | $2.49 | $32.24K | 0.3% | 3.78M | 3.77M |
| Total | −44.02K | -$112.31K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
20.50K shares
Shares
+20.50K
Strike price
2.54
Held after
20.50K
Exercisable
—
6/13/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock20.50K shares | 6/13/2023 | A · Award | +20.50K | 2.54 | — | 20.50K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned654.21K
Total
1.31M indirect1.31M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 654.21K | Indirect |
| Common Stock | 654.21K | Indirect |
| Total | 1.31M | 1.31M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported